Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Tuberculin Skin Test (TST)
    • 1.4.3 Interferon Gamma Released Assay (IGRA)
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Household Contacts with Pulmonary TB
    • 1.5.3 PLHIV
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Latent Tuberculosis Infection (LTBI) Testing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Latent Tuberculosis Infection (LTBI) Testing Industry
      • 1.6.1.1 Latent Tuberculosis Infection (LTBI) Testing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Latent Tuberculosis Infection (LTBI) Testing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Latent Tuberculosis Infection (LTBI) Testing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2015-2026)
  • 2.2 Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
    • 2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Latent Tuberculosis Infection (LTBI) Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Latent Tuberculosis Infection (LTBI) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Market Size
    • 3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio
    • 3.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2019
  • 3.3 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
  • 3.4 Key Players Latent Tuberculosis Infection (LTBI) Testing Product Solution and Service
  • 3.5 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2021-2026)

5 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)
  • 5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
  • 6.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in North America (2019-2020)
  • 6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
  • 6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
  • 7.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
  • 7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
  • 8.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in China (2019-2020)
  • 8.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
  • 8.4 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
  • 9.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
  • 9.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
  • 10.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
  • 11.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in India (2019-2020)
  • 11.3 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
  • 11.4 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
  • 12.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Qiagen
    • 13.1.1 Qiagen Company Details
    • 13.1.2 Qiagen Business Overview and Its Total Revenue
    • 13.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020))
    • 13.1.5 Qiagen Recent Development
  • 13.2 BioMerieux
    • 13.2.1 BioMerieux Company Details
    • 13.2.2 BioMerieux Business Overview and Its Total Revenue
    • 13.2.3 BioMerieux Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.2.4 BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.2.5 BioMerieux Recent Development
  • 13.3 Thermo Fisher Scientific
    • 13.3.1 Thermo Fisher Scientific Company Details
    • 13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
    • 13.3.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.3.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.3.5 Thermo Fisher Scientific Recent Development
  • 13.4 Danaher
    • 13.4.1 Danaher Company Details
    • 13.4.2 Danaher Business Overview and Its Total Revenue
    • 13.4.3 Danaher Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.4.4 Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.4.5 Danaher Recent Development
  • 13.5 Roche
    • 13.5.1 Roche Company Details
    • 13.5.2 Roche Business Overview and Its Total Revenue
    • 13.5.3 Roche Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.5.4 Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.5.5 Roche Recent Development
  • 13.6 Becton Dickinson
    • 13.6.1 Becton Dickinson Company Details
    • 13.6.2 Becton Dickinson Business Overview and Its Total Revenue
    • 13.6.3 Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.6.4 Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.6.5 Becton Dickinson Recent Development
  • 13.7 Agilent Technologies
    • 13.7.1 Agilent Technologies Company Details
    • 13.7.2 Agilent Technologies Business Overview and Its Total Revenue
    • 13.7.3 Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.7.4 Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.7.5 Agilent Technologies Recent Development
  • 13.8 Bio-Rad Laboratories
    • 13.8.1 Bio-Rad Laboratories Company Details
    • 13.8.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
    • 13.8.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.8.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.8.5 Bio-Rad Laboratories Recent Development
  • 13.9 Eppendorf
    • 13.9.1 Eppendorf Company Details
    • 13.9.2 Eppendorf Business Overview and Its Total Revenue
    • 13.9.3 Eppendorf Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.9.4 Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.9.5 Eppendorf Recent Development
  • 13.10 Abbott Laboratories
    • 13.10.1 Abbott Laboratories Company Details
    • 13.10.2 Abbott Laboratories Business Overview and Its Total Revenue
    • 13.10.3 Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
    • 13.10.4 Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
    • 13.10.5 Abbott Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Qiagen
    BioMerieux
    Thermo Fisher Scientific
    Danaher
    Roche
    Becton Dickinson
    Agilent Technologies
    Bio-Rad Laboratories
    Eppendorf
    Abbott Laboratories

    Market segment by Type, the product can be split into
    Tuberculin Skin Test (TST)
    Interferon Gamma Released Assay (IGRA)
    Others
    Market segment by Application, split into
    Household Contacts with Pulmonary TB
    PLHIV
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.
    To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now